| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_163c970d0f90eeb3c5b88c2fc1c1ad30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1993-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb78c39e3c8a7c8e35d0118b48765f4 |
| publicationDate |
1994-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0606506-A1 |
| titleOfInvention |
Beta-lactamase resistant antibacterial composition |
| abstract |
The present invention relates to a beta lactamase-resistant antibacterial composition comprising a combination of sulbactam or its salt and one antibacterial compound selected from the compounds I to IV and their salts, as defined in the specification. In the composition of the present invention, since sulbactam inhibits beta-lactamase activity, the compounds I to IV, which are sensitive to beta-lactamase, can act regardless of beta-lactamase and therefore show a superior antibacterial effect in comparison with the single use of the compounds I to IV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103992337-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103992337-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102372727-A |
| priorityDate |
1993-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |